Latest filing published 06 May 2025 for Organon & Co., €265k.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Kevin Ali: trading record in brief
Kevin Ali is a declared insider of Organon & Co. (chief executive), with filings sourced from SEC (Form 4). In total, 37 filings cover trades dated from 28 February 2022 to 5 May 2025.
Every open-market trade on record is a purchase: 1 purchase worth €265k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 21 share grants and 15 option exercises. So far in 2025, the count stands at 1 purchase and no sales.
Most recently, on 6 May 2025, the filings show an open-market purchase worth €265k in Organon & Co. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kevin Ali
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 34,000 shares@ US$8.805100.0% of flowCommon StockSEC:0001821825-25-000025:0Canonical exit: 3 Aug 2025 (T+90)
- 48,758 shares0Common StockSEC:0001859698-25-000006:0
- 84,222 shares0Common StockSEC:0001859698-25-000004:0
- 21,567 shares0Common StockSEC:0001821825-24-000102:0
- 22,161 shares0Common StockSEC:0001821825-24-000062:0
- 21,471 shares0Common StockSEC:0001821825-24-000046:0
- 88,121 sharesCommon StockSEC:0001821825-24-000009:0
- 22,158 sharesCommon StockSEC:0001209191-23-028095:0
- 2,711 sharesCommon StockSEC:0001209191-23-027170:0
- 21,471 shares0Common StockSEC:0001209191-23-023073:0
- 11,393 sharesCommon StockSEC:0001209191-23-014823:0
- 2,631 sharesCommon StockSEC:0001104659-22-056625:0
- 2,709 sharesCommon StockSEC:0001104659-22-055425:0
- 14,529 sharesCommon StockSEC:0001104659-22-029456:0
14 of 14 declarations
